DR REDDYS LABS
DRREDDY.NS
₹ 4,440.25
2%

Dr Reddy’s Laboratories Ltd

Dr Reddy’s Laboratories Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Dr Reddys is ₹ 4,440.25 that is ₹ 90.70 2.09% with respect to the previous day’s close price. The stock price of Dr Reddys was last updated 1 hour ago.

Dr Reddys Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Dr Reddys Live Share Price Analysis

DR REDDYS LABS
₹ 4,440.25
Open ₹ 4,380.65
High ₹ 4,468.25
Marketcap 737.53B
Close ₹ 4,440.25
Low ₹ 4,360.25
Volume ₹ 597,454.00

The stock of Dr Reddy’s Laboratories Ltd strated the trade at an Open price of ₹ 4,380.65 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 4,468.25 and an Intraday Low price of ₹ 4,360.25%. As per last updated 1 hour ago, the Shares of Dr Reddys were trading at a price of ₹ 4,440.25 which is ₹ 90.70 2.09% as compared the price ₹ 4,349.55 at which the stock close on the previous trading day. The total traded volume for the day stood at 597,454 number of shares.

Candlestick Chart of Dr Reddys Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Dr Reddys Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 4,440.25₹ 3,654.00₹ 4,645.00

Here is Dr Reddys’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 4,645.00. On the lower side, the stock has been to the 52 weeks low price level of ₹ 3,654.00. It’s last traded price was ₹ 4,440.25 as on last update 1 hour ago. The one-year line chart clearly shows how the price of Dr Reddys’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 218.79 per share (EPS TTM) in the trailing twelve months period. Dr Reddys’s last annual dividend rate was 30%, which translates to a 0.68972656% of annual dividend yield.

Line Chart of Dr Reddys Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Dr Reddys

Dr Reddy’s Laboratories Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Dr Reddys are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Dr Reddys

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ALEMBICLTD.NSALEMBIC LTD
₹ 66.55
NSE
₹ 0.3
0.45%

About Dr Reddys

Dr Reddy’s Laboratories Ltd is a Dr. Reddy’s Group Company. The company operates in the Pharmaceuticals & Drugs sector. Incorporated in 1984, it has around 37 years of operations. Dr Reddys live share price is ₹ 4,440.25. It is a Small Cap stock and had a market capitalization of ₹ 737,529,954,304.00 as on 1 hour ago.

The registered office of Dr Reddys is located in Hyderabad, Telangana. The registrar and share transfer agent for Dr Reddys is Bigshare Services Pvt Ltd. The Stock Exchanges on which shares of Dr Reddy’s Laboratories Ltd is listed includes BSE, NSE, MCX, New York.

DR REDDYS LABS
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Employees: 24795
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Address8-2-337, Road No. 3, Hyderabad, India
CountryIndia
Phone91 40 4900 2900
Websitehttps://www.drreddys.com

Dr Reddys Recent News

No Recent News found for Dr Reddy's Laboratories Ltd.